Barx2 Activators
Barx2 Activators is a chemical class that encompasses a group of compounds known for their ability to modulate the activity of the Barx2 transcription factor. Barx2, short for BarH-like homeobox 2, is a critical transcription factor involved in the regulation of various developmental processes and tissue differentiation in multicellular organisms. Its activation and precise control play pivotal roles in embryonic development and tissue homeostasis, making Barx2 Activators an area of significant interest in the field of molecular biology and developmental biology.
Barx2 belongs to the homeobox gene family and possesses a DNA-binding domain that allows it to interact with specific DNA sequences, thereby influencing the transcription of target genes. Barx2 is particularly prominent during craniofacial development, where it regulates the differentiation of various facial structures, including the palate, mandible, and maxilla. Barx2 Activators are compounds that have been identified as capable of enhancing Barx2's transcriptional activity, promoting its binding to target DNA sequences, and thereby influencing the downstream genetic programs involved in tissue development. The modulation of Barx2 by these activators can lead to the fine-tuning of craniofacial morphogenesis, affecting the shape and structure of the face and contributing to the intricate process of facial development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is a derivative of vitamin A and functions as a ligand for retinoic acid receptors (RARs). It can activate Barx2 by binding to RARs, which form complexes with retinoid X receptors (RXRs). These complexes can then act as transcription factors to directly regulate Barx2 gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor. By inhibiting DNA methylation, it can demethylate the Barx2 promoter region, potentially making it more accessible for transcription factors, thus increasing Barx2 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. It promotes histone acetylation, which leads to a more relaxed chromatin structure around the Barx2 gene. This open chromatin structure allows for increased accessibility to transcription factors, potentially enhancing Barx2 transcription. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI activates the canonical Wnt pathway. Activation of Wnt signaling can lead to increased Barx2 expression by modulating downstream targets or transcription factors involved in the Barx2 regulatory network. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
LiCl can activate the Wnt signaling pathway, similar to CHIR9902By activating Wnt signaling, LiCl may indirectly influence Barx2 expression through Wnt-associated regulatory elements. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib inhibits RAF kinases and can indirectly affect Barx2 by modulating the MAPK/ERK pathway. This pathway may have downstream targets that regulate Barx2 transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) signaling. PKC can modulate signaling pathways that intersect with Barx2 regulatory networks, potentially influencing Barx2 expression. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT inhibits the Notch signaling pathway. Cross-talk between Notch and Barx2 pathways in certain contexts means that inhibiting Notch with DAPT can indirectly affect Barx2 expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine inhibits Hedgehog signaling. This inhibition can indirectly impact Barx2 expression, as Hedgehog signaling can cross-talk with Barx2 regulatory networks. | ||||||
SAG | 912545-86-9 | sc-212905 sc-212905A | 1 mg 5 mg | $166.00 $421.00 | 27 | |
SAG activates the Hedgehog signaling pathway, potentially influencing Barx2 expression through downstream targets or regulatory factors. | ||||||